Search Ontology:
ChEBI
nateglinide
- Term ID
- CHEBI:31897
- Synonyms
-
- (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine
- A 4166
- A-4166
- AY 4166
- AY-4166
- AY4166
- Fastic
- N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine
- nateglinida
- nateglinide
- nateglinidum
- Starlix
- Starsis
- trans-N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine
- Definition
- An N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used for the treatment of type 2 diabetes mellitus.
- References
-
- CAS:105816-04-4
- DrugBank:DB00731
- Drug_Central:1886
- HMDB:HMDB0014869
- KEGG:C12508
- KEGG:D01111
- PMID:10820657
- PMID:11585005
- PMID:11724096
- PMID:12652357
- PMID:12918894
- PMID:14748619
- PMID:16178991
- PMID:17253883
- PMID:17573070
- PMID:18200800
- PMID:19337530
- PMID:21801074
- PMID:23229379
- PMID:23675267
- PMID:23867985
- PMID:23872227
- PMID:23935065
- PMID:24563597
- Patent:EP196222
- Patent:US4816484
- Wikipedia:Nateglinide
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from nateglinide
Phenotype where environments contain nateglinide
Phenotype modified by environments containing nateglinide
Human Disease Model